About Us

Dr. Milana Frenkel-Morgenstern's group at Bar-Ilan University’s School of Medicine in the Galilee aims to identify unique potential drug targets in cancer cells, also known as “chimeric RNAs”. Her group catalogs these cancer-associated fusion transcripts, thereby analyzing the function of the proteins produced by the transcripts in order to identify those fusion events that are directly related to biochemical cell function.

Prof. Lars Juhl Jensen's Cellular Network Biology Group at The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen aims to understand the principles that govern complex biological systems such as the cell cycle, signaling networks, and diseases. Most of my work is based on integration of data from high-throughput experiments, sequence analysis, and automatic literature mining.

Dr.Milana Frenkel-Morgenstern Principal Investigator, Bar-Ilan University’s School of Medicine in the Galilee
Prof.Lars Juhl Jensen Professor and Group Leader, Cellular Network Biology Group at The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark
Dr.Dorith Raviv-Shay Lab Manager, Bar-Ilan University’s School of Medicine in the Galilee
Dr.Somnath Tagore Post-doctoral Fellow, Bar-Ilan University’s School of Medicine in the Galilee
Dr.Alessandro Gorohovski Department of Ecology, National Technical University of Ukraine (KPI), Kiev, Ukraine

Contact Information

Dr. Milana Frenkel-Morgenstern
Senior Lecturer / Principal Investigator,
The Faculty of Medicine in the Galilee,
Bar-Ilan University,
Safed, 1311502
ISRAEL